Uncovering the mode of action of engineered T cells in patient cancer organoidsPatient-derived micro-organospheres enable clinical precision oncologyDual targeting of cancer metabolome and stress antigens affects transcriptomic heterogeneity and efficacy of engineered T cellsPatient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identificationRapid tissue prototyping with micro-organospheresMedium-Throughput Drug- and Radiotherapy Screening Assay using Patient-Derived Organoids
author
type
label
Rosemary Millen